儿童肠易激综合征中固有免疫系统激活:粪便人β-防御素-2升高的证据
该研究检测了116例肠易激综合征(IBS)儿童、33例功能性腹痛(FAP)儿童和72例健康对照儿童的粪便β-防御素-2及部分肠道通透性。结果发现IBS和FAP患儿粪便β-防御素-2高于健康对照,IBS组肠道通透性高于FAP和健康对照,β-防御素-2与腹痛症状及肠道通透性相关,提示部分IBS患儿存在固有免疫激活并与腹痛相关。
要点
- IBS和FAP患儿粪便β-防御素-2浓度均高于健康对照儿童。
- IBS女童β-防御素-2高于女性健康对照及IBS男童。
- IBS组肠道通透性高于FAP组和健康对照组。
核心结论
- 部分IBS患儿粪便β-防御素-2升高提示固有免疫系统激活,并与肠道通透性增加及腹痛症状相关。
- 性别是解读IBS患儿β-防御素-2浓度的重要变量。
研究设计与样本
- 研究纳入IBS患儿116例、FAP患儿33例和健康对照儿童72例,IBS和FAP患者来自三级和初级医疗,健康对照来自初级医疗。
- 检测粪便β-防御素-2,并在部分受试者中检测肠道通透性。
主要发现
- IBS患儿β-防御素-2浓度高于健康对照(P = .003),FAP患儿也高于健康对照(P = .03)。
- IBS女童β-防御素-2高于女性健康对照(P = .007),也高于IBS男童(P = .036);FAP组和健康对照组内未见性别差异。
- IBS组肠道通透性高于FAP组和健康对照组(P = .038)。
- 全队列中β-防御素-2与多种疼痛症状相关,IBS组中与疼痛干扰相关(P = .014),FAP组和健康对照组中与疼痛无相关性。
- 全队列中肠道通透性与疼痛发作次数(P = .041)及干扰性疼痛发作次数(P = .049)相关;全队列β-防御素-2与肠道通透性相关(P = .003),IBS组呈边缘相关(P = .086)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The role of the innate immune system in functional gastrointestinal pain disorders is unclear. We investigated the role of β-defensin-2 and gut permeability in childhood irritable bowel syndrome (IBS) and functional abdominal pain (FAP) symptom generation. METHODS: Fecal β-defensin-2 (and in a subset, gut permeability) was measured in children with IBS (n = 116), FAP (n = 33), and healthy control (HC) children (n = 72). IBS and FAP patients were recruited from tertiary and primary care, and HCs were recruited from primary care. RESULTS: β-defensin-2 concentration was greater in children with IBS (P = .003) and FAP (P = .03) than in HCs. β-defensin-2 was greater in girls with IBS than female HCs (P = .007) and in girls with IBS vs boys with IBS (P = .036). There was no difference by sex in the FAP and HC groups. For the entire cohort, β-defensin-2 correlated with multiple pain symptoms. In the IBS group, β-defensin-2 correlated with pain interference (P = .014). No correlation with pain was found in the FAP or HC group. Gut permeability was greater in the IBS vs the FAP and HC groups (P = .038). For the entire cohort, permeability correlated with the number of pain episodes (P = .041) and interfering pain episodes (P = .049). For the entire cohort there was a correlation between β-defensin-2 and permeability (P = .003), with borderline correlation in the IBS group (P = .086). For the cohort and IBS and HC groups, the number of bowel movements was modestly inversely related to fecal β-defensin-2 concentrations. CONCLUSIONS: Increased fecal β-defensin-2 concentration in children with IBS suggests activation of the innate immune system in some, which, along with increased gut permeability, appears related to abdominal pain symptoms. Sex is an important variable in interpreting β-defensin-2 concentration in children with IBS.
引用
- Shulman RJ, Devaraj S, Heitkemper M, et al. Activation of the Innate Immune System in Children With Irritable Bowel Syndrome Evidenced by Increased Fecal Human β-Defensin-2. Clin Gastroenterol Hepatol. 2020. PMID: 32961343. doi:10.1016/j.cgh.2020.09.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。